U.S. markets closed

Kymera Therapeutics, Inc. (KYMR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W
77.51-3.79 (-4.66%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 1/16/2021
Current
9/30/2020
Market Cap (intraday) 5
3.45B1.44B
Enterprise Value 3
3.17B1.30B
Trailing P/E
N/AN/A
Forward P/E 1
N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
149.2668.50
Price/Book (mrq)
11.6913.80
Enterprise Value/Revenue 3
137.3489.58
Enterprise Value/EBITDA 6
-74.28-174.33

Premium access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3133.04%
S&P500 52-Week Change 313.47%
52 Week High 391.92
52 Week Low 325.43
50-Day Moving Average 367.04
200-Day Moving Average 346.17

Share Statistics

Avg Vol (3 month) 3164.95k
Avg Vol (10 day) 3170.4k
Shares Outstanding 544.46M
Float 24.37M
% Held by Insiders 112.00%
% Held by Institutions 139.56%
Shares Short (Dec 30, 2020) 41.05M
Short Ratio (Dec 30, 2020) 44.01
Short % of Float (Dec 30, 2020) 43.24%
Short % of Shares Outstanding (Dec 30, 2020) 42.36%
Shares Short (prior month Nov 29, 2020) 4473.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin -192.45%
Operating Margin (ttm)-196.28%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)23.08M
Revenue Per Share (ttm)3.48
Quarterly Revenue Growth (yoy)1,429.80%
Gross Profit (ttm)-34.22M
EBITDA -44.08M
Net Income Avi to Common (ttm)-53.47M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)293.84M
Total Cash Per Share (mrq)6.61
Total Debt (mrq)18.5M
Total Debt/Equity (mrq)6.28
Current Ratio (mrq)2.77
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)97.4M
Levered Free Cash Flow (ttm)N/A